
US to Impose 200% Tariffs on Indian Generic Drugs
The story in brief
The US plans to impose 200% tariffs on generic drugs from India starting August 2028, which could significantly impact India, as it supplies nearly half of the generic drugs sold in the US. India exported $8.7 billion in pharmaceuticals to the US in 2024, with generics accounting for 31% of its pharmaceutical exports. The move has drawn concern from US officials, including Secretary of State Marco Rubio.